Flulaval Quadrivalent

Product NDC
19515-906
11-digit product format
195150906
Labeler code
19515
Product ID
19515-906_2a9a9563-8797-4c1f-acbf-d2c4ef974e87
Type
VACCINE
Nonproprietary name
influenza virus vaccine
Dosage form
SUSPENSION
Route
INTRAMUSCULAR
Labeler
ID Biomedical Corporation of Quebec
Application
BLA125163
Marketing category
BLA
Marketing start
2019-07-02
Marketing end
2020-06-30
Substance
INFLUENZA A VIRUS A/BRISBANE/02/2018 IVR-190 (H1N1) ANTIGEN (UV, FORMALDEHYDE INACTIVATED); INFLUENZA A VIRUS A/KANSAS/14/2017 X-327 (H3N2) ANTIGEN (UV, FORMALDEHYDE INACTIVATED); INFLUENZA B VIRUS B/PHUKET/3073/2013 ANTIGEN (UV, FORMALDEHYDE INACTIVATED); INFLUENZA B VIRUS B/MARYLAND/15/2016 BX-69A ANTIGEN (UV, FORMALDEHYDE INACTIVATED)
Active strength
15 ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL
NDC exclude flag
No
Listing certified through
0000-00-00
Current FDA listing
Historical FDA.report record

NDC auxiliary status#

Explicit status records from FDA unfinished, excluded, and compounder auxiliary files. Absence of a row is not itself a regulatory status. Browse every current auxiliary row, including rows without a usable NDC. · Browse every captured source and parsed snapshot.

Current NDC status page 1 of 1 · 2 matching rows.

Dataset, Scope, Product NDC table
DatasetScopeProduct NDCPackage NDCCodeStatusReporting periodSource date
excluded productproduct19515-906DDiscontinued by firm2026-07-31
excluded packagepackage19515-90619515-906-52DDiscontinued by firm2026-07-31

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
19515-906-41ML - Milliliter19515-906413c1ebb-972f-4ff6-a6e0-e46db55aea9312019-08-06
19515-906-52ML - Milliliter19515-906c411f9b7-8afc-4ed3-aa38-980ca96a6d0912019-08-06

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLAProprietary nameProper nameLicense typeStatusLatest source
125163Flulaval, Flulaval QuadrivalentInfluenza Vaccine351(a)Rx2026-06-01